The FDA lacks authority to require notification from manufacturers when a plant shuts down, which could lead to a drug shortage.
Editor's note · Context
Mikulski points out regulatory gaps that contribute to drug shortages.
Share
More from Barbara Mikulski
Will the Senator withhold for just 1 minute? Will the chairman of the committee yield for a question? This is not to hold you up, but I do have a question for the chairman of the committee.
I want to add my voice of sadness and regret for the loss of Pat Summitt. I extend my deepest sympathy to her family, friends, and the entire Lady Vols community. Pat Summitt was a trailblazer for all American women. I am honored to be a…
It will be a proud day for our country when every girl who visits the National Mall is able to see herself represented amongst the giants of our national story.
I rise for a final time as the vice chair of the Appropriations Committee. Tonight, as we get ready to vote, these will be the last votes I will cast in the U.S. Senate. The ones we do today and possibly tomorrow will write my final…





